10Apr/14

Natco seeks to block Gilead's hepatitis C drug patent in India: source – Reuters


Economic Times

Natco seeks to block Gilead’s hepatitis C drug patent in India: source
Reuters
Gilead, whose medicine has been hailed by doctors as a breakthrough in treating the liver-destroying disease, has come under fire over its product’s $1,000 per pill price tag in the United States. India’s patent laws allow a third party to dispute the
WHO joins clamour to make new hepatitis C pills affordableDaily News & Analysis
Gilead aims to license hepatitis C drug to 3-4 Indian firmsReuters India
US drug industry group defends price of Gilead hepatitis drugChicago Tribune (blog)
USTrade Voice –Businessweek
all 222 news articles »
10Apr/14

Teen at Pennsylvania high school stabs 22 – Times of India


Times of India

Teen at Pennsylvania high school stabs 22
Times of India
At least five students were critically wounded in the attack on Wednesday, including a boy whose liver was pierced by a knife thrust that narrowly missed his heart and aorta, doctors said. Others also suffered deep abdominal puncture wounds. The
Knife-wielding student wounds 22 in Pennsylvania schoolDaily News & Analysis
Student with 2 knives stabs 21 at US schoolCalcutta Telegraph

all 2,422 news articles »